Everest Medicines Limited

SZSC:1952 Stock Report

Market Cap: HK$6.4b

Everest Medicines Past Earnings Performance

Past criteria checks 0/6

Everest Medicines has been growing earnings at an average annual rate of 23.5%, while the Biotechs industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 92% per year.

Key information

23.5%

Earnings growth rate

131.3%

EPS growth rate

Biotechs Industry Growth11.0%
Revenue growth rate92.0%
Return on equity-17.0%
Net Margin-670.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Everest Medicines makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSC:1952 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23126-844397540
30 Sep 2373-424440646
30 Jun 2321-3483753
31 Mar 2317-125543781
31 Dec 2213-247603810
30 Sep 227-770581759
30 Jun 221-1,294558708
31 Mar 221-1,151500661
31 Dec 210-1,009441613
30 Sep 210-3,213395540
30 Jun 210-5,418350467
31 Mar 210-6,154315423
31 Dec 200-5,658311377
31 Mar 200-10118208
31 Dec 190-21555151

Quality Earnings: 1952 is currently unprofitable.

Growing Profit Margin: 1952 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1952 is unprofitable, but has reduced losses over the past 5 years at a rate of 23.5% per year.

Accelerating Growth: Unable to compare 1952's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1952 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (22.1%).


Return on Equity

High ROE: 1952 has a negative Return on Equity (-17%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.